Boehringer Ingelheim Vetmedica and the Feline Advisory Bureau (FAB) have launched Spot The Signs, a campaign designed to help owners spot the signs of painful, age-related conditions in cats, such as arthritis.

According to the company, which makes Metacam…

Boehringer Ingelheim Vetmedica is giving veterinary practices the chance to offer cat owners a free 3ml pack of Metacam to trial treatment in cats with chronic pain.

Boehringer says each free Metacam pack will provide up to seven days' pain relief to an…

Boehringer Ingelheim Vetmedica has launched trial size Seraquin dispensing strips so clients can try a week's supply of the veterinary joint support supplement for cats and dogs.

Rob Lucy, brand manager for Seraquin, said: "With 9 out of 10 dogs…

Boehringer Ingelheim has rebranded its equine joint supplement, Seraquin GLME, as Equitop GLME.

Equitop GLME is a palatable, pearl formulation joint supplement developed to support the healthy function of cartilage, joint capsules, tendons and ligaments…

Boehringer Ingelheim Animal Health has announced the launch of Arti-Cell Forte, the first stem cell-based veterinary medicine to get marketing authorisation for treating equine lameness, calling it a 'breakthrough medicine for degenerative joint disease…

Boehringer Ingelheim has received UK marketing authorisation for RenuTend - the first licensed treatment to improve healing of tendon injuries and suspensory ligaments in horses.

Renutend contains primed mesenchymal stem cells (MSCs) which Boehringer says…

Boehringer Ingelheim has launched Arthritis AWARE, a campaign to raise awareness that osteoarthritis is much more common in young dogs than previously thought.

Although the disease is commonly diagnosed later in life, a 2022 study of 123 dogs found that…